Manufacturing Technology. (i) PDL-Lead Manufacturer. Notwithstanding the foregoing, with respect to Collaboration Products or Royalty Products for which PDL is the Manufacturing Party under Article 8 above, PDL shall have the right to decide which Third Party Technology will be used in such Manufacturing, and any agreement pursuant to which PDL acquired or acquires such technology shall be deemed a Third Party License.
Manufacturing Technology. “Manufacturing Technology” means any and all specifications (raw material (including API) and finished product), protocols, documentation and instructions (including validation, quality control and assurance, storage and other supporting documentation) and master batch records Controlled by Santarus, in each case (a) in the form used in the manufacture (including packaging, labeling, quality control and assurance testing and storage and handling) of Licensed Products under authority of Santarus as of the date of GSK’s written notice described in Section 5.3.2 and (b) reasonably necessary for GSK to manufacture or have manufactured Licensed Products pursuant to this Agreement.
Manufacturing Technology. Applied Manufacturing Option Course Title Course # Offered Plan to Take Grade Credits Prerequisites Credentialing of MassMEP CNC Machine Operator Skills Training & Advanced CNC Machine Operator Skills Training as per articulation agreement = 26 credits Semester 1 English Composition & Literature I ENG 101 F/S/SU 3 ENG 100 or appropriate placement score Process Automation and Robotics MNT 000 X 0 XXX 000, XXX 000 Mathematics Elective --- 3 Social Science Elective --- 3 Elective* --- 3-4 Semester 2 English Composition & Literature II ENG 102 F/S/SU 3 ENG 101 Introduction to Business MGT 101 F/S/SU 3 ENG 091 with a grade of “C” or higher and passing the ENG 096 departmental writing final examination essay or appropriate placement score Humanities Elective --- 3 Mathematics Elective --- 3 Science Elective --- 4 Elective* --- 3-4 Total credits required 60-62 * Elective: Students MUST select from the following list of courses: BUS 205 Project Management (3 credits) ENG 205 Technical & Workplace Writing (3 credits) MGT 211 Principles of Management (3 credits) MNT 103 Solid Modeling (3 credits) MNT 105 Geometric Tolerancing & Dimensioning (4 credits) MNT 216 Manufacturing Processes II (4 credits) MNT 218 Lean Manufacturing & Six Sigma (3 credits)
Manufacturing Technology. Upon a Trigger Event or exercise of the Sanofi Option, MannKind will: (i) transfer to Sanofi or its Affiliate any and all Manufacturing Technology necessary to enable Sanofi or its Affiliate or sublicensee to Manufacture Product in accordance with the Product Specifications and (ii) otherwise provide Sanofi or its Affiliate the technology transfer services described in Section 6.6(c) reasonably necessary to enable Sanofi or its Affiliate or sublicensee to Manufacture and supply Product in accordance with Product Specifications. At Sanofi’s request, MannKind shall promptly provide to Sanofi copies of all agreements between MannKind or its Affiliates and Third Party suppliers, vendors, or distributors that relate to the supply of any Raw Materials used in or in connection with the Products in the Territory. Upon a Trigger Event or exercise of the Sanofi Option, MannKind shall promptly and reasonably cooperate to assist Sanofi in obtaining the benefits of any Third Party agreements of MannKind relating to the Products (including assisting Sanofi in identifying and contacting such Third Party suppliers, agreeing to relieve such Third Party suppliers of any exclusivity obligations to MannKind, etc.). For the sake of clarity, the costs incurred by MannKind in performing such activities (i) in the event of a Trigger Event, shall be borne by MannKind and shall not be reflected in the Paid Price, Estimated COGS and/or Cost of Goods, and shall not be considered Allowable Expenses for purposes of Exhibit B to the License Agreement and (ii) in the event of the exercise of the Sanofi Option, shall be reimbursed by Sanofi and shall be considered Allowable Expenses for purposes of Exhibit B to the License Agreement.
Manufacturing Technology. Within [***] after the Effective Date, Daiichi Sankyo will provide to Rain or to a contract manufacturer selected by Rain and reasonably approved by Daiichi Sankyo in accordance with Section 2.3, the documents, reports, data, analytical reports, and other information listed in Exhibit H. Such provision of documents, reports, data, analytical reports, and any other information will be done through an electronic data room or other reasonable means, as determined by Daiichi Sankyo after consulting with Rain. Daiichi Sankyo will provide such documents, reports, data, analytical reports, and other information in the language in which it was drafted and Daiichi Sankyo shall not be obligated to translate such documents.
Manufacturing Technology. Notwithstanding anything contained herein to the contrary, MERCK shall have the right to grant sublicenses under the license granted to it under Sections 6.1.1(c) and 6.1.2(c) solely to Third Party subcontractors engaged by MERCK to Manufacture API, Collaboration Compound or Product or to Affiliates; provided however, that; (a) MERCK shall remain responsible for the satisfactory accomplishment of such work in accordance with the terms and conditions of this Agreement; and (b) each such subcontractor shall enter into a written agreement containing such provisions as are normal and customary for similar types of agreements. In addition, in the event that this Agreement terminates pursuant to Section 9.2, or in the event that MERCK and its Approved Manufacturers fail to supply ARIAD as set forth in Section 3.5.4, and subject to the limitation set forth in Section 6.1.2(c) with respect to MERCK Manufacturing Technology and MERCK Patent rights that relate to the Manufacture of Product from API, ARIAD shall have the right to grant sublicenses under the license granted to it under Section 6.1.2(c) to Third Parties to manufacture (x) Product, solely in the case of termination pursuant to Section 9.2, (y) API, Collaboration Compound, Rapamycin Analogs, Rapamycin Derived mTOR Inhibitors, and (z) rapamycin for use in manufacture of Rapamycin Analogs or Rapamycin Derived mTOR Inhibitors, and (i) to use the same for research use by ARIAD, (ii) to use and sell the same for sale by ARIAD to ARIAD’s Medical Device Collaborators, and (iii) to use and sell the same for any purpose except as prohibited by this Agreement or the New Supply Agreement.
Manufacturing Technology. Manufacturing technology which is Controlled by one Party and which would be useful to the other Party in discharging its manufacturing obligations hereunder shall be made available to the manufacturing Party for that purpose, subject to negotiation of a reasonable compensation arrangement. If either Party (a “Contracting Party”) engages an Affiliate or a Third Party to provide assistance to the Contracting Party in the development of processes useful for the manufacture of Bulk Drug Substance or Drug Product, the Contracting Party will make reasonable efforts to provide that any processes belonging to that Affiliate or Third Party and made available to the Contracting Party will also be made available to the other Party on the same terms offered to the Contracting Party.
Manufacturing Technology. Within [**Redacted**] Business Days after the Effective Date, Daiichi Sankyo will provide to AnHeart, the documents, reports, data, analytical reports, and other information listed in Exhibit G that are necessary to manufacture the Licensed Compound and Product(s). Such provision of documents, reports, data, analytical reports, and any other information will be done through an electronic data room or other reasonable means, as determined by Daiichi Sankyo after consulting with AnHeart. Daiichi Sankyo will provide data and study reports in the original language and Daiichi Sankyo shall not be obligated to translate such documents.
Manufacturing Technology. As soon as practicable following a ------------------------ request by Salix, Biorex shall disclose to Salix all Manufacturing Technology in existence at such time, and shall thereafter promptly (and in any event at least quarterly) provide Salix with updates or additions to such Manufacturing Technology that are subsequently developed or acquired by Biorex or its Affiliates. In addition, Biorex shall use all reasonable efforts to so provide to Salix all similar items and information generated or developed by or for other licensees of Biorex and to permit Salix to use such items and information to the same extent it may use Manufacturing Technology hereunder.
Manufacturing Technology. (i) Except as described in SCHEDULE 4.1(H), Seller owns or has the lawful right and license to use the Manufacturing Technology. Except as set forth on SCHEDULE 4.1(H), the Manufacturing Technology contains all of the know-how necessary for the manufacture and sale of the Product in the Territory as and where conducted by Seller during the twelve (12) month period prior to the Closing.
